GeneDx Reports Second Quarter 2026 Financial Results
Go back to GeneDx Reports Second Quarter 2026 Financial Results| (NASDAQ: WGS) | Delayed: 77.93 -4.46 (5.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.39 | 52 Week High | $ | |||
| Open | $82.58 | 52 Week Low | $ | |||
| Day High | $83.11 | P/E | N/A | |||
| Day Low | $77.93 | EPS | $ | |||
| Volume | 507,363 | |||||

